In metabolic diseases, such as obesity, NAFLD andT2D, CD4+ T cell differentiated cells, such as Th1, Th2, Th17, and Tregs, all play potential roles in disease regulation or progression. This evidence concerns the gene CD4 and metabolic dysfunction-associated steatotic liver disease.